Drug extravasation with Enfortumab vedotin

INTRODUCTION: Enfortumab vedotin is an antibody drug conjugate approved for management of pretreated locally advanced or metastatic urothelial carcinoma, which is associated with a rare risk of drug extravasation and soft tissue reactions. CASE REPORT: We report two cases of EV extravasation with su...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Christopher Ryan, de Kouchkovsky, Dimitri, Kalebasty, Arash Rezazadeh, Mar, Nataliya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612376/
https://www.ncbi.nlm.nih.gov/pubmed/37401244
http://dx.doi.org/10.1177/10781552231185505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612376/
https://www.ncbi.nlm.nih.gov/pubmed/37401244
http://dx.doi.org/10.1177/10781552231185505

Ejemplares similares